RecalledThisWeek Search
Low risk Drugs & MedicationsClass III

Supernus Pharmaceuticals, Inc. Recall

Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY

Updated August 31, 2026

Supernus Pharmaceuticals, Inc. is recalling Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY. Hazard: Failed dissolution specifications.

Is the Supernus Pharmaceuticals, Inc. recalled? Yes. This product was recalled by FDA on August 31, 2026. Details below.

What is recalled

Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30.

Am I affected

You may be affected if you own this product. Check the brand, model, and lot/date codes listed in the recall against your item.

What to do right now

Voluntary: Firm initiated

The hazard

Failed dissolution specifications.

Brands affected

Supernus Pharmaceuticals, Inc.
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0833-2026
Classification
Class III
Recalled
August 31, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls